APA (7th ed.) Citation

Alharbi, A. S., Abu-Shraie, N., Al Abdulkarim, H., Alharbi, I. H., Averin, A., Law, A. W., . . . Mousa, M. (2026). Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. Infectious Diseases & Therapy, 1. https://doi.org/10.1007/s40121-026-01386-5

Chicago Style (17th ed.) Citation

Alharbi, Adel S., et al. "Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus." Infectious Diseases & Therapy 2026: 1. https://doi.org/10.1007/s40121-026-01386-5.

MLA (9th ed.) Citation

Alharbi, Adel S., et al. "Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus." Infectious Diseases & Therapy, 2026, p. 1, https://doi.org/10.1007/s40121-026-01386-5.